Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in Italy-Reference-Cited by-同舟云学术

Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in Italy

Published:2022-06-14 Issue:4 Volume:87 Page:1467-1474
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Valletta Martina¹,Canevelli Marco¹²,D’Antonio Fabrizia¹,Trebbastoni Alessandro¹,Talarico Giuseppina¹,Campanelli Alessandra¹,Sepe Monti Micaela¹,Di Vita Antonella¹,Salati Emanuela¹,Imbriano Letizia¹,Margiotta Roberta¹,Barbetti Sonia¹,Diana Sofia¹,Buscarnera Simona¹,Toccaceli Blasi Marco¹,Salzillo Martina¹,Pugliese Giuseppe¹,Vanacore Nicola²,Bruno Giuseppe¹

Affiliation:

1. Department of Human Neuroscience, “Sapienza” University, Rome, Italy

2. National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy

Abstract

This study aimed to explore the prevalence and safety of SARS-CoV-2 vaccination in individuals with dementia. Patients with mild cognitive impairment or dementia were recruited at a tertiary memory clinic, from March 15 to September 15, 2021. Information on COVID-19 vaccination and adverse events experienced after vaccine administration were collected from caregivers. Two-hundred-seventy subjects were finally recruited. Among them, 253 (93.7%) had received the vaccine and only 69 (27.3%) experienced adverse events. Cognitive and behavioral changes following immunization were only rarely reported. COVID-19 vaccination is safe and well-tolerated in patients with cognitive impairment who should be prioritized in the vaccination campaign.

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference32 articles.

1. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study;Ge;PLoS One,2021

2. The impact of dementia on the clinical outcome of COVID-19: A systematic review and meta-analysis;Liu;J Alzheimers Dis,2020

3. Prevalence and clinical correlates of dementia among COVID-19-related deaths in Italy;Canevelli;Alzheimers Dement (Amst),2020

4. Prevalence and prognostic value of delirium as the initial presentation of COVID-19 in the elderly with dementia: An Italian retrospective study;Poloni;EClinicalMedicine,2020

5. Promoting COVID-19 vaccine acceptance: Recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA;Omer;Lancet,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Global trends in COVID-19 Alzheimer's related research: a bibliometric analysis;Frontiers in Neurology;2023-06-05

3. The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms;Translational Neurodegeneration;2022-09-11